caa a22 4500 605491828 CHVBK 20210128105157.0 cr unu---uuuuu 210128e20150401xx s 000 0 eng 10.1007/s10147-015-0801-z doi (NATIONALLICENCE)springer-10.1007/s10147-015-0801-z Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer [Elektronische Daten] [Toshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada, Shinji Tanaka, Yoshinori Ito, Yoichi Ajioka, Tetsuya Hamaguchi, Ichinosuke Hyodo, Masahiro Igarashi, Hideyuki Ishida, Soichiro Ishihara, Megumi Ishiguro, Yukihide Kanemitsu, Norihiro Kokudo, Kei Muro, Atsushi Ochiai, Masahiko Oguchi, Yasuo Ohkura, Yutaka Saito, Yoshiharu Sakai, Hideki Ueno, Takayuki Yoshino, Narikazu Boku, Takahiro Fujimori, Nobuo Koinuma, Takayuki Morita, Genichi Nishimura, Yuh Sakata, Keiichi Takahashi, Osamu Tsuruta, Toshiharu Yamaguchi, Masahiro Yoshida, Naohiko Yamaguchi, Kenjiro Kotake, Kenichi Sugihara] Colorectal cancer is a major cause of death in Japan, where it accounts for the largest number of deaths from malignant neoplasms among women and the third largest number among men. Many new methods of treatment have been developed during recent decades. The Japanese Society for Cancer of the Colon and Rectum Guidelines 2014 for treatment of colorectal cancer (JSCCR Guidelines 2014) have been prepared as standard treatment strategies for colorectal cancer, to eliminate treatment disparities among institutions, to eliminate unnecessary treatment and insufficient treatment, and to deepen mutual understanding among health-care professionals and patients by making these guidelines available to the general public. These guidelines have been prepared as a result of consensuses reached by the JSCCR Guideline Committee on the basis of careful review of evidence retrieved by literature searches and taking into consideration the medical health insurance system and actual clinical practice in Japan. They can, therefore, be used as a guide for treating colorectal cancer in clinical practice. More specifically, they can be used as a guide to obtaining informed consent from patients and choosing the method of treatment for each patient. As a result of the discussions of the Guideline Committee, controversial issues were selected as clinical questions, and recommendations were made. Each recommendation is accompanied by a classification of the evidence and a classification of recommendation categories, on the basis of consensus reached by Guideline Committee members. Here we present the English version of the JSCCR Guidelines 2014. Japan Society of Clinical Oncology, 2015 Colorectal cancer nationallicence Guideline nationallicence Surgery nationallicence Chemotherapy nationallicence Endoscopy nationallicence Radiotherapy nationallicence Watanabe Toshiaki Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan aut Itabashi Michio Department of Surgery 2, Tokyo Women's Medical University, Tokyo, Japan aut Shimada Yasuhiro Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan aut Tanaka Shinji Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan aut Ito Yoshinori Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan aut Ajioka Yoichi Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan aut Hamaguchi Tetsuya Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan aut Hyodo Ichinosuke Division of Gastroenterology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan aut Igarashi Masahiro Department of Endoscopy, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan aut Ishida Hideyuki Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan aut Ishihara Soichiro Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan aut Ishiguro Megumi Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan aut Kanemitsu Yukihide Colorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan aut Kokudo Norihiro Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan aut Muro Kei Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan aut Ochiai Atsushi Pathology Division, Research Center for Innovative Oncology, National Cancer Centre Hospital East, Chiba, Japan aut Oguchi Masahiko Radiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan aut Ohkura Yasuo Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan aut Saito Yutaka Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan aut Sakai Yoshiharu Department of Surgery, Kyoto University, Kyoto, Japan aut Ueno Hideki Department of Surgery, National Defense Medical College, Saitama, Japan aut Yoshino Takayuki Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan aut Boku Narikazu Department of Clinical Oncology, St. Marianna University, Kawasaki, Japan aut Fujimori Takahiro Department of Surgical and Molecular Pathology, Dokkyo Medical University School of Medicine, Tochigi, Japan aut Koinuma Nobuo Department of Health Administration and Policy, Tohoku Pharmaceutical University, Miyagi, Japan aut Morita Takayuki Department of Surgery, Cancer Center, Aomori Prefectural Central Hospital, Aomori, Japan aut Nishimura Genichi Department of Surgery, Japanese Red Cross Kanazawa Hospital, Ishikawa, Japan aut Sakata Yuh CEO, Misawa City Hospital, Aomori, Japan aut Takahashi Keiichi Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan aut Tsuruta Osamu Division of GI Endoscopy, Kurume University School of Medicine, Fukuoka, Japan aut Yamaguchi Toshiharu Department of Gastroenterological Surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan aut Yoshida Masahiro Department of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare, Chiba, Japan aut Yamaguchi Naohiko Library, Toho University Medical Center Sakura Hospital, Chiba, Japan aut Kotake Kenjiro Department of Surgery, Tochigi Cancer Center, Tochigi, Japan aut Sugihara Kenichi Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan aut International Journal of Clinical Oncology Springer Japan 20/2(2015-04-01), 207-239 1341-9625 20:2<207 2015 20 10147 https://doi.org/10.1007/s10147-015-0801-z text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s10147-015-0801-z text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Watanabe Toshiaki Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan aut NATIONALLICENCE 700 1- Itabashi Michio Department of Surgery 2, Tokyo Women's Medical University, Tokyo, Japan aut NATIONALLICENCE 700 1- Shimada Yasuhiro Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Tanaka Shinji Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan aut NATIONALLICENCE 700 1- Ito Yoshinori Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Ajioka Yoichi Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan aut NATIONALLICENCE 700 1- Hamaguchi Tetsuya Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Hyodo Ichinosuke Division of Gastroenterology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan aut NATIONALLICENCE 700 1- Igarashi Masahiro Department of Endoscopy, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan aut NATIONALLICENCE 700 1- Ishida Hideyuki Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan aut NATIONALLICENCE 700 1- Ishihara Soichiro Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan aut NATIONALLICENCE 700 1- Ishiguro Megumi Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan aut NATIONALLICENCE 700 1- Kanemitsu Yukihide Colorectal Surgery Division, National Cancer Center Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Kokudo Norihiro Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan aut NATIONALLICENCE 700 1- Muro Kei Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan aut NATIONALLICENCE 700 1- Ochiai Atsushi Pathology Division, Research Center for Innovative Oncology, National Cancer Centre Hospital East, Chiba, Japan aut NATIONALLICENCE 700 1- Oguchi Masahiko Radiation Oncology Department, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan aut NATIONALLICENCE 700 1- Ohkura Yasuo Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan aut NATIONALLICENCE 700 1- Saito Yutaka Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Sakai Yoshiharu Department of Surgery, Kyoto University, Kyoto, Japan aut NATIONALLICENCE 700 1- Ueno Hideki Department of Surgery, National Defense Medical College, Saitama, Japan aut NATIONALLICENCE 700 1- Yoshino Takayuki Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan aut NATIONALLICENCE 700 1- Boku Narikazu Department of Clinical Oncology, St. Marianna University, Kawasaki, Japan aut NATIONALLICENCE 700 1- Fujimori Takahiro Department of Surgical and Molecular Pathology, Dokkyo Medical University School of Medicine, Tochigi, Japan aut NATIONALLICENCE 700 1- Koinuma Nobuo Department of Health Administration and Policy, Tohoku Pharmaceutical University, Miyagi, Japan aut NATIONALLICENCE 700 1- Morita Takayuki Department of Surgery, Cancer Center, Aomori Prefectural Central Hospital, Aomori, Japan aut NATIONALLICENCE 700 1- Nishimura Genichi Department of Surgery, Japanese Red Cross Kanazawa Hospital, Ishikawa, Japan aut NATIONALLICENCE 700 1- Sakata Yuh CEO, Misawa City Hospital, Aomori, Japan aut NATIONALLICENCE 700 1- Takahashi Keiichi Department of Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan aut NATIONALLICENCE 700 1- Tsuruta Osamu Division of GI Endoscopy, Kurume University School of Medicine, Fukuoka, Japan aut NATIONALLICENCE 700 1- Yamaguchi Toshiharu Department of Gastroenterological Surgery, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan aut NATIONALLICENCE 700 1- Yoshida Masahiro Department of Hemodialysis and Surgery, Chemotherapy Research Institute, International University of Health and Welfare, Chiba, Japan aut NATIONALLICENCE 700 1- Yamaguchi Naohiko Library, Toho University Medical Center Sakura Hospital, Chiba, Japan aut NATIONALLICENCE 700 1- Kotake Kenjiro Department of Surgery, Tochigi Cancer Center, Tochigi, Japan aut NATIONALLICENCE 700 1- Sugihara Kenichi Department of Surgical Oncology, Graduate School, Tokyo Medical and Dental University, Tokyo, Japan aut NATIONALLICENCE 773 0- International Journal of Clinical Oncology Springer Japan 20/2(2015-04-01), 207-239 1341-9625 20:2<207 2015 20 10147 SWISSBIB 493446923